Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
04/27/2022 | 10:44pm EDT
April 28, 2022
Name of listed company:
Chugai Pharmaceutical Co., Ltd.
Code number:
4519 (Prime Market of Tokyo Stock Exchange)
Head office:
1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
President & CEO:
Osamu Okuda
Inquiries to:
Toshiya Sasai
Head of Corporate Communications Dept.
Tel: +81-(0)3-3273-0554
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 28, 2022--Chugai Pharmaceutical Co., Ltd.announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 29, 2022. The result of treasury shares is as follows.
Chugai Pharmaceutical Co. Ltd. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 02:43:07 UTC.